Synonyms: | |
Status: | Phase 3 |
Entry Type: | Small molecule |
Molecule Category: | UNKNOWN |
ATC: | M02AA29 |
UNII: | J5ZZK9P7MX |
InChI Key | SYTBZMRGLBWNTM-JTQLQIEISA-N |
---|---|
Smile | |
InChI |
|
Property Name | Value |
---|---|
Molecular Formula | C15H13FO2 |
Molecular Weight | 244.26 |
AlogP | 3.68 |
Hydrogen Bond Acceptor | 1.0 |
Hydrogen Bond Donor | 1.0 |
Number of Rotational Bond | 3.0 |
Polar Surface Area | 37.3 |
Molecular species | ACID |
Aromatic Rings | 2.0 |
Heavy Atoms | 18.0 |
Action | Mechanism of Action | Reference |
---|---|---|
INHIBITOR | Cyclooxygenase inhibitor | Other |
Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
---|---|---|---|---|---|---|
Enzyme
Oxidoreductase
|
- | 2000 | - | - | - | |
Enzyme
Protease
Aspartic protease
Aspartic protease AD clan
Aspartic protease A22A subfamily
Aspartic protease A22A regulatory subfamily
|
- | - | - | - | 37 | |
Enzyme
|
- | 2000 | - | - | 37 | |
Ion channel
Other ion channel
Miscellaneous ion channel
Presenilin ER Ca2+ leak channel family
|
- | - | - | - | 37 | |
Membrane receptor
Family A G protein-coupled receptor
Peptide receptor (family A GPCR)
Chemokine receptor
CXC chemokine receptor
|
- | - | - | - | 22 |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Sprains and Strains | 2 | D013180 | ClinicalTrials |
Resources | Reference |
---|---|
ChEBI | 42446 |
ChEMBL | CHEMBL435298 |
DrugBank | DB16159 |
DrugCentral | 5060 |
FDA SRS | J5ZZK9P7MX |
Guide to Pharmacology | 9420 |
PDB | FLP |
PubChem | 72099 |
SureChEMBL | SCHEMBL505817 |
ZINC | ZINC000000000323 |